M&A

M&A is down, but Big Pharma likely to line up 'multiple shots on goal' in 2nd half, PwC says
Fierce Biotech
Fri, 06/24/22 - 10:25 am
M&A
biotech
Pfizer
GSK
PwC
In first M&A strike, Paul Stoffels lays out 5-year plan to turn Galapagos around
Fierce Biotech
Thu, 06/23/22 - 10:54 am
Galapagos
Pharma CEOs
Paul Stoffels
M&A
CAR-T
AboundBio
CellPoint
SVB Leerink's Pro-forma Analysis Of Speculated Merck/Seagen Deal
Yahoo/Benzinga
Wed, 06/22/22 - 10:50 am
Merck
Seagen
M&A
North America’s Largest lntegrated Research Site Organization, Centricity Research, Expands Further with Addition of Aventiv Research
CP Wire
Wed, 06/22/22 - 10:40 am
Centricity Research
Clinical Research
Aventiv Research
M&A
BMS, Pfizer and Merck face steep patent cliffs but all have the financial flexibility for M&A: Moody's
Fierce Pharma
Tue, 06/21/22 - 11:56 pm
Pfizer
Merck
Bristol Myers Squibb
patents
patent cliffs
M&A
Bioventus Finds Alternative Option to Acquire CartiHeal
Medical Devices and Diagnostics Industry
Tue, 06/21/22 - 11:47 pm
Bioventus
CartiHeal
Medtech
M&A
Report: Merck Looks into Possible Buyout of Seagen
BioSpace
Mon, 06/20/22 - 10:38 am
Merck
Seagen
M&A
Rumor mill says AstraZeneca may be eyeing a takeover of Mereo
Pharmaforum
Fri, 06/17/22 - 10:41 am
AstraZeneca
Mereo BioPharma
M&A
Pharma under the microscope as FTC considers new ways to review acquisitions
BioPharma Dive
Fri, 06/17/22 - 10:38 am
FTC
M&A
Boston Scientific Takes Majority Stake in M.I. Tech
Medical Devices and Diagnostics Industry
Wed, 06/15/22 - 07:20 pm
Medtech
devices
Boston Scientific
M&A
MI Tech
Boehringer Ingelheim Signs Option to Acquire Immunology Partner, Trutino Biosciences
BioSpace
Wed, 06/15/22 - 10:56 am
Boehringer Ingelheim
Trutino Biosciences
M&A
cancer
ResMed Converts High Demand for Sleep Apnea Machines into High-Value M&A
Medical Devices and Diagnostics Industry
Wed, 06/15/22 - 10:53 am
ResMed
Medtech
devices
M&A
sleep apnea
Medifox Dan
SPAC merger called off as company connected to ex-Purdue CEO decides to remain private
Endpoints
Mon, 06/13/22 - 09:47 pm
Blade Therapeutics
Purdue Pharma
SPAC
M&A
Zymeworks adds a classic poison pill defense to the armory as the biotech's board battles hostile takeover
Endpoints
Mon, 06/13/22 - 10:34 am
Zymeworks
M&A
poison pill
Yumanity's end: J&J pays $26M for neuroscience assets as reverse merger erases biotech
Fierce Biotech
Mon, 06/6/22 - 10:29 am
Yumanity Therapeutics
JNJ
Kineta
Merck
M&A
Bristol Myers bets $4B on Turning Point and its targeted cancer drugs
BioPharma Dive
Fri, 06/3/22 - 10:56 am
Bristol Myers Squibb
M&A
Turning Point Therapeutics
Why Pfizer Needs a High-Growth Pipeline
Motley Fool
Fri, 06/3/22 - 09:13 am
Pfizer
COVID-19
vaccines
M&A
Boston Scientific would be ‘good fit’ for increasingly acquisitive J&J, analysts say
Medtech Dive
Wed, 06/1/22 - 09:59 am
JNJ
M&A
Boston Scientific
devices
Medtech
Pfizer, already flush with cash, will reap $16B from selling shares in GSK consumer health spinoff
Fierce Pharma
Wed, 06/1/22 - 09:57 am
Pfizer
GSK
consumer health
M&A
GSK acquiring Affinivax and its next-generation pneumonia vaccine for $2.1 billion upfront
BioPharma Dive
Tue, 05/31/22 - 10:53 am
GSK
M&A
Affinivax
vaccines
pneumococcal disease

Pages